1. Chieh WC, Zouboulis CC. Hormones and pilosebaceous unit. Dermatoen-docrinology 2009;1:81-6.
2. Biro FM, Emans SJ. Whither PCOS? The challenges of establishing hyperandrogenism in adolescent girls. J Adolesc Health 2008;43:103-5.
3. Eisner JR, Dumesic DA, Kemnitz JW, Abbott DH. Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys. J Clin Endocrinol Metab 2000;
85:1206-10.
4. Ibanez L, Jaramillo A, Enriquez G, Miro E, Lopez-Bermejo A, Dunger D, de Zegher F. Polycystic ovaries after precocious pubarche: relation to prenatal growth. Hum Reprod 2007;22:395-400.
5. Witchel SF. Hyperandrogenism in adolescents. Adolesc Med 2002;13:89-99.
6. Legro RS, Castracane VD, Kaufman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 2004;
59:141-54.
7. Ibanez L, Potau N, Francois I, de Zegher F. Precocious pubarche, hyper-insulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin EndocrinolMetab 1998;83:3558-62.
8. de Vries L, Karasik A, Landau Z, Phillip M, Kiviti S, Goldberg-Stern H.
Endocrine effects of valproate in adolescent girls with epilepsy. Epilepsia
2007;48:470-7.
9. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
10. Rossi R, Tauchmanovâ L, Luciano A, et al. Functional hyperandrogenism detected by corticotropin and GnRHanalogue stimulation tests in women affected by apparently idiopathic hirsutism. J Endocrinol Invest 2001;24:
491-8.
11. Azziz R, Carmina E, Sawaya ME. Idiopathic hirsutism. Endocr Rev 2000;4:
347-62.
12. Unluhizarci K, Kula M, Dundar M, Tanriverdi F, Israel S, ColakRet al. The prevalence of non-classic adrenal hyperplasia among Turkish women with hyperandrogenism. Gynecol Endocrinol2010;26:139-43.
13. Unluhizarci K, Kaltsas G, Kelestimur F. Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism. Eur J Clin Invest
2012;42:86-94.
14.
Gökç
e M, Darendeliler F. Çocuk ve adolesanlarda hiperandrojenizm. Editörler: Ercan O, Alikaşifoğlu M, Ercan G. Adolesan Sağlığı (içinde). İ.Ü. Cerrahpaşa Tıp Fakültesi Sürekli Tıp Eğitimi Etkinlikleri Sempozyum
Dizisi 2005;43:169-78.
15. Chanmandari E, Kino T, Ichijo T, Chrousos GP. Generalized glucocor-ticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. J Clin Endocrinol Metab 2008;93:1563-72.
16. Ferriman D, Gallwey JD. Clinical assesment of body hair in women. JCEM 1961;21:1440-7.
17. Bona G, Bozzola M, Buzi F, De Sanctis C, De Sanctis V, Radetti G, Rigon F, Tato L, Tonini G, Bernasconi S. Hirsutism. Minerva Pediatr 2007;59:
289-98.
18. Kurtoğlu S, Hatipoğlu N, Akın L. Çocukluk çağında hirsutizm ve polik-istik over sendromuna yaklaşım. Türkiye Klinikleri. J Endocrin-Special Topics
2009;2:70-80.
19. Slayden SM, Moran C, Sams WM Jr, Boots LR, Azziz R. Hyperandrogene-mia in patients presenting with acne. Fertil Steril 2001;75:889-92.
20. Young J, Tardy V, de la Perriere AB, Bachelot A, Morel Y. Detection and management of late-onset 21-hydroxylase deficiency in women with hyperandrogenism. Ann Endocrinol 2010;71:14-8.
21. New MI, Lorenzen F, Lerner AJ, ve ark. Genotyping steroid 21-hydrox-ylase deficiency: hormonal reference data. J Clin Endocrinol Metab 1983;57: 320-6.
22. Driscoll DA. Polycystic ovary syndrome in adolescence. Semin ReprodMed
2003;21:301-7
23. Rosenfield RL, Cara JF. Androgens and the adolescent girl. In: Sanfilippo JP, Muram D, Dewhurst J, Lee PA. (eds). Pediatric and Adolescent
Gynecology. Philadelphia: WB Saunders; 2001;269-94.
24. Silfen ME, Denburg MR, Manibo AM, Lobo RO et al. Early endocrine,
metabolic and gonadotropic characteristics of PCOS: Comparison between nonobese and obese adolescents. JCEM2003;88:4682-8.
25. Fruzzetti F, Perini D, Lazzarini V, Parrini D, Genazzani AR, Fruzzetti F. Adolescent girls with polycystic ovary syndrome showing different phe-notypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril 2009;92:626-34.
26. Michelmore KF, Balen AH, Dunger DB, Vessey MP Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol (Oxf 1999;51:779-86.
27. Chen Y. Yang D, Li L, Chen X. The role of ovarian volume as a diag-nastic criterian for Chinese adolescents with polycystic ovary syndome. J
Pediatr Adolesc Gynecol2008;21:347-50.
28. Escobar-Morreale HF. Diagnosis and management of hirsutism. Ann N Y
Acad Sci2010;1205:166-74.
29. Hoeger K. Obesity and weight loss in polycystic ovary syndrome. Obstet
Gynecol Clin North Am2001;28:85-97.
30. Redmond GP, Olson WH, Lippman JS, Kafrissen ME, Jones TM,
Jorizzo JL. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial. Obstet Gynecol 1997;89:
615-22.
31. Gordon CM. Menstrual disorders in adolescents. Excess androgens and the polycystic ovary syndrome. Pediatr Clin North Am 1999;46:519-43.
32. Somani N, Harrison S, Bergfeld WF. The clinical evaluation of hirsutism.
Dermatol Ther2008;21:376-91.
Thank you for copying data from http://www.arastirmax.com
